Principal Financial Group Inc. cut its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 65.8% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 213,583 shares of the company's stock after selling 411,358 shares during the period. Principal Financial Group Inc. owned 0.23% of Acadia Healthcare worth $6,476,000 as of its most recent SEC filing.
A number of other institutional investors have also recently added to or reduced their stakes in ACHC. Signaturefd LLC lifted its holdings in Acadia Healthcare by 460.6% in the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company's stock worth $48,000 after buying an additional 1,004 shares in the last quarter. Quadrant Capital Group LLC lifted its holdings in Acadia Healthcare by 287.1% in the 4th quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company's stock worth $50,000 after buying an additional 933 shares in the last quarter. UMB Bank n.a. lifted its holdings in Acadia Healthcare by 149.5% in the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after buying an additional 755 shares in the last quarter. State of Wyoming acquired a new position in Acadia Healthcare in the 4th quarter worth $56,000. Finally, Covestor Ltd raised its stake in shares of Acadia Healthcare by 27.2% in the 4th quarter. Covestor Ltd now owns 1,450 shares of the company's stock valued at $58,000 after purchasing an additional 310 shares in the last quarter.
Acadia Healthcare Stock Performance
Shares of NASDAQ:ACHC traded up $0.09 during trading on Thursday, reaching $22.77. 912,252 shares of the company's stock traded hands, compared to its average volume of 1,862,115. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.35 and a quick ratio of 1.35. Acadia Healthcare Company, Inc. has a 12 month low of $20.36 and a 12 month high of $82.41. The company has a 50 day moving average of $23.14 and a 200-day moving average of $30.43. The stock has a market capitalization of $2.10 billion, a P/E ratio of 11.22, a price-to-earnings-growth ratio of 4.43 and a beta of 0.93.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its earnings results on Monday, May 12th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.35 by $0.05. Acadia Healthcare had a net margin of 5.94% and a return on equity of 8.72%. The firm had revenue of $770.51 million during the quarter, compared to analysts' expectations of $769.90 million. During the same quarter in the prior year, the firm earned $0.84 EPS. Acadia Healthcare's quarterly revenue was up .3% on a year-over-year basis. On average, equities analysts expect that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.
Analysts Set New Price Targets
ACHC has been the topic of a number of recent analyst reports. Wall Street Zen upgraded shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research note on Thursday, May 22nd. Mizuho cut their target price on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research note on Wednesday, May 14th. Guggenheim initiated coverage on shares of Acadia Healthcare in a research note on Wednesday, April 9th. They issued a "buy" rating and a $36.00 target price on the stock. KeyCorp cut their target price on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Finally, Barclays cut their target price on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a research note on Wednesday, May 14th. Five research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $47.94.
View Our Latest Stock Report on ACHC
Acadia Healthcare Profile
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Recommended Stories

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.